Patients with Barrett's esophagus (dysplasia or early cancer) should be treated and monitored by expert endoscopists and ...
These foci of dysplasia were missed by the standard-of-care procedure, which blindly biopsies a tiny fraction of the esophageal tissue using a prescribed systematic pattern, but were caught by the ...
Z-line=level of mucosal squamo-columnar junction; EGJ=esophagogastric junction; BE= Barrett's esophagus; HGD=high-grade dysplasia; EGD=esophagogastroduodeoscopy. * In selected patients such as the ...
This cohort included 78 people with a normal esophagus, 77 with BE, 12 with high-grade dysplasia, five with low-grade dysplasia, one with indeterminate dysplasia and 61 with esophageal adenocarcinoma.
Gastroenterology 122(2), 588-590 (2002). Haggitt RC. Barrett's esophagus, dysplasia and adenocarcinoma. Hum. Pathol. 25(2), 982-993 (1994). Sharma P, Marcon N, Wani S et al. Non-biopsy detection ...
This cohort included 78 people with a normal esophagus, 77 with BE, 12 with high-grade dysplasia, five with low-grade dysplasia, one with indeterminate dysplasia and 61 with esophageal adenocarcinoma.
In this publication, titled Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Barrett's Esophagus Patients, Esopredict was performed at multiple locations and time ...
This cohort included 78 people with a normal esophagus, 77 with BE, 12 with high-grade dysplasia, five with low-grade dysplasia, one with indeterminate dysplasia and 61 with esophageal adenocarcinoma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback